Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

307 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Early Huntington's Disease: Impulse Control Deficits but Correct Judgment Regarding Risky Situations.

Galvez V, Fernandez-Ruiz J, Bayliss L, Ochoa-Morales A, Hernandez-Castillo CR, Díaz R, Campos-Romo A.

J Huntingtons Dis. 2017 Mar 21. doi: 10.3233/JHD-160223. [Epub ahead of print]

0

0

0

PUBMED

Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease.

McGarry A, Kieburtz K, Abler V, Grachev ID, Gandhi S, Auinger P, Papapetropoulos S, Hayden M.

J Huntingtons Dis. 2017 Aug 12. doi: 10.3233/JHD-170241. [Epub ahead of print]

0

0

0

PUBMED

A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles.

Southwell AL, Skotte NH, Villanueva EB, Østergaard ME, Gu X, Kordasiewicz HB, Kay C, Cheung D, Xie Y, Waltl S, Dal Cengio L, Findlay-Black H, Doty CN, Petoukhov E, Iworima D, Slama R, Ooi J, Pouladi M

Hum Mol Genet. 2017 Jan 18. pii: ddx021. doi: 10.1093/hmg/ddx021. [Epub ahead of print]

0

0

0

PUBMED

Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?

Lodi R.

Neurology. 2017 Jan 10;88(2):116-117. doi: 10.1212/WNL.0000000000003497. No abstract available.

0

0

0

PUBMED

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.

Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC.

Parkinsonism Relat Disord. 2017 Nov 2. pii: S1353-8020(17)30424-8. doi: 10.1016/j.parkreldis.2017.11.001. [Epub ahead of print]

0

0

0

PUBMED

Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease.

Gomez-Pastor R, Burchfiel ET, Neef DW, Jaeger AM, Cabiscol E, McKinstry SU, Doss A, Aballay A, Lo DC, Akimov SS, Ross CA, Eroglu C, Thiele DJ.

Nat Commun. 2017 Feb 13;8:14405. doi: 10.1038/ncomms14405.

0

0

0

PUBMED

Cognitive decline in Huntington's disease expansion gene carriers.

Baake V, Reijntjes RHAM, Dumas EM, Thompson JC; REGISTRY Investigators of the European Huntington's Disease Network., Roos RAC.

Cortex. 2017 Aug 3;95:51-62. doi: 10.1016/j.cortex.2017.07.017. [Epub ahead of print]

0

0

0

PUBMED

Bringing naloxone to ground zero: Huntington, West Virginia.

Babcock C, Rockich-Winston N, Booth C.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S9-S10. doi: 10.1016/j.japh.2016.09.006. Epub 2016 Nov 9. No abstract available.

0

0

0

PUBMED

Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.

Yu M, Fu Y, Liang Y, Song H, Yao Y, Wu P, Yao Y, Pan Y, Wen X, Ma L, Hexige S, Ding Y, Luo S, Lu B.

Cell Res. 2017 Dec;27(12):1441-1465. doi: 10.1038/cr.2017.113. Epub 2017 Oct 13.

0

0

0

PUBMED

Huntington disease.

Nold CS.

JAAPA. 2017 Mar;30(3):46-47. doi: 10.1097/01.JAA.0000512243.43624.33. No abstract available.

0

0

0

PUBMED

Characterisation of progressive motor deficits in whisker movements in R6/2, Q175 and Hdh knock-in mouse models of Huntington's disease.

Garland H, Wood NI, Skillings EA, Detloff PJ, Morton AJ, Grant RA.

J Neurosci Methods. 2017 May 1. pii: S0165-0270(17)30119-X. doi: 10.1016/j.jneumeth.2017.04.020. [Epub ahead of print]

0

0

0

PUBMED

Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington's disease.

Skov M, Dirksen RT.

J Gen Physiol. 2017 Jan;149(1):49-53. doi: 10.1085/jgp.201611728. No abstract available.

0

0

0

PUBMED

Huntington's disease-like 2 with an expansion mutation of the Junctophilin-3 gene; first reported case from Botswana.

Ocampo C, Daimari R, Oyekunle AA.

J Clin Neurosci. 2017 Oct 21. pii: S0967-5868(17)31493-5. doi: 10.1016/j.jocn.2017.10.025. [Epub ahead of print]

0

0

0

PUBMED

Feasibility of computerized working memory training in individuals with Huntington disease.

Sadeghi M, Barlow-Krelina E, Gibbons C, Shaikh KT, Fung WLA, Meschino WS, Till C.

PLoS One. 2017 Apr 28;12(4):e0176429. doi: 10.1371/journal.pone.0176429. eCollection 2017.

0

0

0

PUBMED

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

Soylu-Kucharz R, Sandelius Å, Sjögren M, Blennow K, Wild EJ, Zetterberg H, Björkqvist M.

Sci Rep. 2017 Oct 26;7(1):14114. doi: 10.1038/s41598-017-14179-1.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy